$11.10 Last:
-3.39% Change Percent:
$11.56 Open:
$11.10 Previous Close:
$11.848 High:
$10.85 Low:
12,176,569 Volume:
02/26/2021 04:55:40 pm Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
Stock Date | Open Price | Close Price | High | Low | Volume |
---|---|---|---|---|---|
2021-02-26 | 11.56 | 11.1 | 11.848 | 10.85 | 12,176,569 |
2021-02-25 | 12.09 | 11.49 | 12.79 | 11.34 | 11,472,602 |
2021-02-24 | 11.81 | 12.01 | 12.17 | 11.5 | 8,219,732 |
2021-02-23 | 12.1 | 11.68 | 12.14 | 10.9 | 16,319,686 |
2021-02-22 | 13.68 | 12.88 | 13.9 | 12.815 | 10,893,185 |
2021-02-19 | 14.07 | 13.84 | 14.37 | 13.7 | 8,916,200 |
2021-02-18 | 14.88 | 13.97 | 15.34 | 13.83 | 15,412,472 |
2021-02-17 | 13.55 | 15.365 | 15.41 | 13.26 | 17,250,538 |
2021-02-16 | 14.52 | 13.78 | 14.95 | 13.58 | 17,421,686 |
2021-02-15 | 15.42 | 14.22 | 16.08 | 14.18 | 46,247,952 |
2021-02-12 | 15.42 | 14.22 | 16.08 | 14.18 | 46,008,687 |
2021-02-11 | 13.07 | 13 | 13.39 | 12.71 | 8,645,677 |
2021-02-10 | 13.73 | 12.98 | 14.03 | 12.85 | 8,820,399 |
2021-02-09 | 13.89 | 13.78 | 14.01 | 13.1411 | 9,124,443 |
2021-02-08 | 13 | 13.87 | 14.35 | 12.6 | 17,506,755 |
2021-02-05 | 13.17 | 12.835 | 13.39 | 12.51 | 11,898,345 |
2021-02-04 | 14.58 | 12.595 | 14.58 | 12.11 | 18,703,172 |
2021-02-03 | 14.73 | 14.56 | 15.01 | 13.66 | 22,682,569 |
2021-02-02 | 18.97 | 15.09 | 19 | 13.82 | 47,398,834 |
2021-02-01 | 13.76 | 16.96 | 18.2 | 13.3 | 93,939,094 |
Inovio Pharmaceuticals Inc. Company Name:
INO Stock Symbol:
NASDAQ Market:
Inovio Pharmaceuticals Inc. Website:
News, Short Squeeze, Breakout and More Instantly...
The way we think about treating brain cancers is being quietly revolutionized, buried beneath recent headline-grabbing announcements pertaining to COVID-19. A series of discoveries and breakthroughs in oncology, especially those targeting glioblastoma —the most common and aggress...
Liquid biopsy-based precision test guides patient selection and offers potential for cost-effective, non-invasive alternative to surgical removal of cervical lesions QIAGEN’s bioinformatic expertise raises predictive biomarker power in INOVIO’s patient selectio...
INOVIO and QIAGEN expand collaboration to develop next generation sequencing (NGS) companion diagnostic for INOVIO's VGX-3100 for advanced cervical dysplasia - Liquid biopsy-based precision test guides patient selection and offers potential for cost-effective, non-invasive alter...